Journal of the Korean Society of Radiology (한국방사선학회논문지)

The Korean Society of Radiology (한국방사선학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of Dose Distribution between the Techniques of Non-small Cell Lung Cancer

비소세포폐암의 방사선 치료기법간의 선량분포의 비교

  • Lee, Seung-chul (Department of Radiological Technology, Dongshin University) ;
  • Kim, Young-jae (Department of Radiologic Technology, Daegu Health College) ;
  • Jang, Seongjoo (Department of Radiological Technology, Dongshin University)
  • 이승철 (동신대학교 방사선학과) ;
  • 김영재 (가톨릭대학교 의정부성모병원 방사선종양학과) ;
  • 장성주 (동신대학교 방사선학과)
  • Received : 2016.04.12
  • Accepted : 2016.06.30
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Comparison of the dose aspect that radiation therapy treatments using IMRT, tomotherapy, mArc (modulated arc therapy). The experimental subject is non-small cell lung cancer patient. The prescription dose is 58.0 Gy to the volume of PTV(planning target volume). and spinal cord, esophagus, and liver organ is the normal organ(OAR, organ at risk). Average PTV value is 57.60 Gy in mArc and 61.04 Gy in tomotherapy and 58.95 Gy in IMRT. The average dose of the Esophagus is 2.84 Gy in m-Arc, 5.14 Gy in tomotherapy, 1.84 Gy in IMRT. The average dose of the Liver is 19.44 Gy in m-Arc, 12.22 Gy in tomotherapy, 21.97 Gy in IMRT. The average dose of the Spinal cord is 5.72 Gy in m-Arc, 7.08 Gy in tomotherapy, 6.15 Gy in IMRT. Results of this study is no significant difference between mArc and tomotherapy and Linac based IMRT in dose study and also, mArc's dose coverage and dose volume histogram is better than IMRT and tomotherapy. but, This study is limited to a disease of cancer. in addition, fewer number of groups. The wide range the more research can be developed patient-specific treatment techniques and be applied to the patients

방사선 치료시 최근 많이 쓰이고 있는 IMRT, Tomotherapy, mArc(modulation arc therapy)의 치료법을 선량적인 측면에서 상호 비교하고자 한다. 비소세포성 폐암의 환자를 대상으로 하여 치료계획용적에 58.0 Gy를 처방선량을 기준으로 설정하였으며 주변 정상장기는 척수, 식도, 간을 설정 하였다. PTVmean는 mArc의 경우 57.60 Gy, Tomotherapy가 61.04 Gy, IMRT는 58.95 Gy이었다. 식도(Esophagus)의 평균선량은 mArc가 2.84 Gy였고, Tomotherapy가 5.14 Gy, IMRT가 1.84 Gy로 나타났다. 간(Liver)은 mArc는 19.44 Gy, Tomotherpy가 12.22 Gy, IMRT는 21.97 Gy이었고 척수(Spinal Cord)은 mArc 5.72 Gy, Tomotherapy가 7.08 Gy, IMRT는 6.15 Gy로 측정되었다. 또한, 선량포함도와 선량체적곡선 등의 자료를 관찰해 본 결과 mArc와 Tomotherapy 그리고 IMRT의 결과와 현저한 차이를 보이지는 않았다. 하지만, 본 연구는 폐암이라는 질환으로 한정하였었고 실험군의 수가 적은 단점을 가지고 있으므로 좀 더 많은 질환과 환자를 대상으로 연구를 폭넓게 진행 한다면 환자 맞춤형 치료기법을 개발하여 적용될 것으로 사료된다.

Keywords

References

  1. ICRU, International Commission on Radiation Units and Measurements. Report 62: Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), 1999.
  2. Bae JM, Won YJ, Jung KW, Suh KA, Ahn DH, Park JG : Annaual report of the central cancer registry in Korea-1999 : Based on registered data from 128 hospitals. Cancer Res Treat Vol. 33, No. 5, pp. 367-72, 2001. https://doi.org/10.4143/crt.2001.33.5.367
  3. Mackie TR, "History of Tomotherapy" Phys Med Biol, Vol. 51, pp. 427-453, 2006. https://doi.org/10.1088/0031-9155/51/13/R24
  4. Kron T et al, Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol, Vol. 49, pp. 3675-3690, 2004. https://doi.org/10.1088/0031-9155/49/16/014
  5. Hae-Jin Park, Mi-Hwa Kim, Mison Chun, Yeong-Teak Oh, Tae-Suk Suh, "Effects of Arc Number or Rotation Range upon Dose Distribution at RapidArc Planning for Liver Cancer", Korean society of Medical physics, Vol. 21, No. 2, pp. 165-173, 2010.
  6. Bae JM, Won YJ, Jung KW, Suh KA, Ahn DH, Park JG, "Annaual report of the central cancer registry in Korea-1999 : Based on registered data from 128 hospitals", Cancer Res Treat, Vol. 33, No. 5, pp. 367-72, 2001. https://doi.org/10.4143/crt.2001.33.5.367
  7. HY Kim, MP Jung, DS Heo, "Lung Cancer on Korean(1980-1984)", Kor J of Medicine, Vol. 46, pp. 221-8, 1994.
  8. Perez CA, Stanley K, Rubin P, et al, "A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group", Journals of Cancer, Vol. 45, pp. 2744-53, 1980.
  9. Perez CA, bauer M, Edelstein S, et al, "Impact of tumor control on survival in carcinoma of the lung treated with irradiation", Int J Radiat Oncol Biol Phys, Vol. 12, pp. 539-47, 1986. https://doi.org/10.1016/0360-3016(86)90061-1
  10. Perez CA, Pajak TF, Rubin P, et al, "Long-term observations of the patterns of failure in patients with unresectable nonoat cell carcinoma of the lung treated with definitive radiotheapy", Journals of Cancer, Vol. 59, pp. 1874-81, 1987.
  11. Emami B, Purdy J, Harms W, et al, "Three dimensional treatment planning for lung cancer", Int J Radiat Oncol Biol Phys, Vol. 21, pp. 217-27, 1991.
  12. Graham MV, Matthews JW, Harms WB, et al, "3-D radiation treatment planning study for patients with carcinoma of the lung" Int J Radiat Oncol Biol Phys, Vol. 29, pp. 1105-17, 1994. https://doi.org/10.1016/0360-3016(94)90407-3
  13. MJ Lee, HJ Jung, Radiotherapy for Nasopharyngeal Carcinoma, Journal of Radiation Oncology, Vol. 21 No. 4, pp. 269-275, 2003.
  14. Tomas Kron, Grigor Grigorov, Edward Yu et al"Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy". Phys Med Biol, Vol. 49, pp. 3675-3690, 2004. https://doi.org/10.1088/0031-9155/49/16/014
  15. L Z. Nisce, M., W. Geller, M.D. et al. Experience with a new technique for "total node" irradiation Hodgkin's disease. British Journal of Radiology, Vol. 47, pp. 108-111, 1974. https://doi.org/10.1259/0007-1285-47-554-108
  16. Youngjae Kim, Gwanguk Seol, The Study of Dose Distribution according to the Using Linac and Tomotherapy on Total Lymphnode Irradiation, JKSR, Vol. 7, No. 4, pp. 285-291, 2013.